Ann: AusCann Releases Low-dose Form Capsule, page-31

If you look at the announcement from Dec 2019 and then read this announcement, I think we can safely deduce (IMO) that the trial(s) is scheduled to occur between now and the expected release of finalized product to market (by the end of June 2020).

This is what Ido stated 18 Dec 2019: “We remain focused on making AusCann’s capsules available for prescription to patients in Australia during the first half of 2020. Our goal is to provide high-quality medicine and to obtain detailed, data-driven evaluations regarding the outcomes of AusCann’s pharmaceutical treatment. These results will build the clinical evidence supporting the unique benefits of AusCann’s capsules necessary to open a large market for the Company.”

The guidance criteria has been stated in this release "The Therapeutic Goods Administration’s (TGA) guidance document1 suggests that the general principle for medicinal cannabis dosing should be “start low, go slow”. ". If that's what the TGA has said, then that's the approach that should be taken.

Ido has also stated in this release “Reliable, stable and standardised medicines are critical in order to generate quality clinical evidence for cannabinoid-based medicines. This evidence is a prerequisite to market expansion and medical acceptance by healthcare professionals. We remain committed to making our dose-controlled capsules commercially available for prescription to patients in Australia in the first half of 2020 through the TGA special access scheme and authorised prescriber scheme.”

It seems straight forward to me. Could it change and/or be delayed? Yes, but it doesn't look that way to me at this point? My take away from this recent release is that things are still on track and that AC8 will be starting low in dosing potency.

I think Fyou has me on block - ha ha ha! Someone with a handle of "Fyou" has blocked someone - that made me laugh! Fyou too, hey - ha ha ha. 彼は知らない

All IMO DYOR.